Latest News & Features
Generics
Galderma Laboratories has sued Lupin Pharmaceuticals alleging that it plans to manufacture and sell a generic version of Oracea prior to the expiration of key patents. 7 December 2021
Americas
Johnson & Johnson’s subsidiary Ethicon has obtained a permanent injunction against counterfeiters selling fake versions of Surgicel, an absorbable haemostat used to control bleeding during surgery. 7 December 2021
article
From the old theory that medical costs will destroy a nation to the recent theory that Opdivo do the same, balancing a national health insurance system with medical finances has been an urgent issue. 3 December 2021
article
Life sciences innovators at all stages seek patent protection to limit market competition and, in some cases, attract further investment. Careful IP planning is especially important in the life sciences, with many companies relying on a handful of patents to protect their high-value products. It is essential that companies pay close attention to the interrelationship between patent and US Food and Drug Administration regulatory considerations to protect their most valuable assets for the long term. 2 December 2021
Americas
Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents. 2 December 2021
Americas
Moderna has failed to reverse an unfavourable ruling related to its COVID-19 vaccine technology, after the US Court of Appeals for the Federal Circuit upheld the validity of a patent owned by Arbutus Biopharma. 2 December 2021
Americas
The US Court of Appeals for the Federal Circuit has refused Biogen’s attempt to revive a key patent for its multiple sclerosis drug Tecfidera (dimethyl fumarate), leaving Mylan’s successful challenge intact. 2 December 2021
Americas
A US subsidiary of German skin treatment company Biofrontera has resolved its dispute with Dusa Pharmaceuticals, on the eve of a trial over patents covering a light therapy used to treat skin conditions, called BLU-U. 30 November 2021
Big Pharma
The US Court of Appeals for the Federal Circuit has affirmed a US Patent Trial and Appeal Board decision that held that claims of a patent for dissolvable films containing therapeutic agents were anticipated. 30 November 2021
Big Pharma
The World Trade Organization has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year. 29 November 2021